Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

• Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US. • In optimal cytoreduction HIPEC is the standard treatment. • In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy.

Detalles Bibliográficos
Autores principales: Grzankowski, Kassondra S., Brightwell, Rachel M., Kasznica, John M., Odusi, Kunle O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434159/
https://www.ncbi.nlm.nih.gov/pubmed/26076085
http://dx.doi.org/10.1016/j.gore.2014.11.002
_version_ 1782371737458966528
author Grzankowski, Kassondra S.
Brightwell, Rachel M.
Kasznica, John M.
Odusi, Kunle O.
author_facet Grzankowski, Kassondra S.
Brightwell, Rachel M.
Kasznica, John M.
Odusi, Kunle O.
author_sort Grzankowski, Kassondra S.
collection PubMed
description • Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US. • In optimal cytoreduction HIPEC is the standard treatment. • In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy.
format Online
Article
Text
id pubmed-4434159
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44341592015-06-05 Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator Grzankowski, Kassondra S. Brightwell, Rachel M. Kasznica, John M. Odusi, Kunle O. Gynecol Oncol Rep Case Report • Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US. • In optimal cytoreduction HIPEC is the standard treatment. • In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy. Elsevier 2014-11-17 /pmc/articles/PMC4434159/ /pubmed/26076085 http://dx.doi.org/10.1016/j.gore.2014.11.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Case Report
Grzankowski, Kassondra S.
Brightwell, Rachel M.
Kasznica, John M.
Odusi, Kunle O.
Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title_full Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title_fullStr Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title_full_unstemmed Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title_short Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
title_sort malignant peritoneal mesothelioma without asbestos exposure: an ovarian cancer imitator
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434159/
https://www.ncbi.nlm.nih.gov/pubmed/26076085
http://dx.doi.org/10.1016/j.gore.2014.11.002
work_keys_str_mv AT grzankowskikassondras malignantperitonealmesotheliomawithoutasbestosexposureanovariancancerimitator
AT brightwellrachelm malignantperitonealmesotheliomawithoutasbestosexposureanovariancancerimitator
AT kasznicajohnm malignantperitonealmesotheliomawithoutasbestosexposureanovariancancerimitator
AT odusikunleo malignantperitonealmesotheliomawithoutasbestosexposureanovariancancerimitator

Ejemplares similares